Biotech
FeaturesThe Moderna COVID-19 vaccine was the ultimate home run for this biotech venture firm. It’s a tough act to follow
By Paolo ConfinoAugust 10, 2023
LeadershipInside Illumina’s $8 billion deal that spurred a proxy fight with Carl Icahn and the ouster of 2 prominent Black Silicon Valley executives
By Lila MacLellanJuly 27, 2023
FinanceThe A.I. mania is so red hot that a small $50 million investment from Nvidia sent an obscure biotech firm’s shares up a record 78%
By Angel Adegbesan and BloombergJuly 12, 2023
By Tiago Ramos Alfaro and BloombergJune 11, 2023
NewslettersCan an A.I. algorithm spot the next Facebook or Uber? The founder of this European VC firm thinks so
By Lucy BrewsterMay 24, 2023
NewslettersA.I.-fueled biotech startups are having a moment—and one just raised $300 million in a Series A
By Lucy BrewsterMay 23, 2023
HealthHow Horizon Therapeutics sold to Amgen for $27.8 billion without ever licensing a drug of its own
By Arthur Allen and KFF Health NewsApril 13, 2023
By Angelica Peebles, Ilena Peng and BloombergMarch 10, 2023
By Lucy BrewsterOctober 24, 2022
By Lucy BrewsterSeptember 23, 2022
By Tristan BoveSeptember 12, 2022
By Riley Griffin and BloombergSeptember 10, 2022
By Jared Whitlock and Kaiser Health NewsJuly 21, 2022
By Michelle McMurry-HeathMay 2, 2022
Most Popular
